Home › Companies › Guardant Health, Inc. › 2025-2026
Compiled from SEC Form N-PX filings and Guardant Health, Inc.’s Form 8-K, filed June 18, 2026 (Item 5.07 on EDGAR). Page generated October 25, 2026.
Meeting of June 17, 2026: 5 items on Guardant Health, Inc.’s Form 8-K, filed June 18, 2026: 2 elected · 1 approved · 1 not approved · 1 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore Guardant Health, Inc. in the interactive database Compare manager voting policies
These tallies are Guardant Health, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 18, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Ian Clark | 70,526,891 | -- | -- | 37,916,548 | 7,714,711 | 65% | Elected | — |
| Elect Director: Manuel Hidalgo Medina | 81,925,123 | -- | -- | 26,518,316 | 7,714,711 | 76% | Elected | — |
| 2. A proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026 | 115,899,030 | 15,250 | 243,870 | -- | -- | 99.9% | Approved | — |
| 3. A proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers | 98,236,639 | 9,905,190 | 301,610 | -- | 7,714,711 | 91% | Not approved Filing and tally disagree The company's filing says not approved; its own tally shows 91% FOR. | — |
| 4. A proposal to determine, on an advisory (non-binding) basis, the frequency of future stockholder advisory votes regarding the compensation of the Company's named executive officers, was determined | 107,997,996 | -- | 165,727 | -- | 7,714,711 | — | Not verified | — |
Source: Guardant Health, Inc., Form 8-K, filed with the SEC on June 18, 2026 — read the filing on EDGAR.
Each item below shows how the 491 asset managers that disclosed a Guardant Health, Inc. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 5 wordings of this item as funds reported it.
65% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Ian Clark
Guardant Health, Inc.’s own tally for this item (“Elect Director: Ian Clark”): 70,526,891 for, 37,916,548 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 28, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors by the following vote:”
Support: 65% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,124,570 | 0 | 110 | 13,443 | For |
| Fidelity | 7,481,853 | 0 | 0 | 34,165 | For |
| BlackRock | 4,372,397 | 0 | 0 | 290,503 | Mixed |
| T. Rowe Price | 4,136,333 | 0 | 0 | 313,904 | Mixed |
| Capital Group | 3,309,597 | 0 | 0 | 0 | For |
| Invesco | 3,074,252 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 2,341,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,809,744 | 0 | 0 | 0 | For |
| Federated Hermes | 0 | 0 | 0 | 1,770,539 | Withhold |
| Franklin Custodian Funds | 1,750,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 0 | 1,651,800 | Withhold |
| Lord Abbett | 1,552,726 | 0 | 0 | 0 | For |
| Charles Schwab | 1,469,568 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 743,506 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 173,377 | 0 | 0 | 477,656 | Mixed |
| Victory Capital | 0 | 0 | 0 | 564,540 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 558,736 | Withhold |
| FRANKLIN STRATEGIC SERIES | 553,257 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 548,018 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 517,922 | Withhold |
| ALGER FUNDS | 0 | 0 | 0 | 480,988 | Withhold |
| Jackson National | 293,554 | 0 | 0 | 172,282 | Mixed |
| ARK ETF Trust | 446,882 | 0 | 0 | 0 | For |
| Equitable | 192,309 | 0 | 0 | 246,059 | Mixed |
| Principal | 0 | 0 | 0 | 392,815 | Withhold |
Fund voting reports, all 127 managers: 48,843,219 for, 13,794,843 withheld, 110 abstained, 152 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 0 | 0 | 815,917 | Withhold |
| Keel Point, LLC | 0 | 0 | 0 | 2,167 | Withhold |
| Berkeley Capital Partners, LLC | 110 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 25 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 135 for, 818,084 withheld.
Combines 5 wordings of this item as funds reported it.
76% Majority: yes · of votes cast
Description as filed by funds: Election of Class II Directors: Manuel Hidalgo Medina
Guardant Health, Inc.’s own tally for this item (“Elect Director: Manuel Hidalgo Medina”): 81,925,123 for, 26,518,316 withheld, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “All of the nominees for director listed in Proposal 1 in the Company's Definitive Proxy Statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 28, 2026 (the "Proxy Statement"), were elected to serve on the Company's board of directors by the following vote:”
Support: 76% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,131,643 | 0 | 80 | 6,400 | For |
| Fidelity | 7,509,418 | 0 | 0 | 6,600 | For |
| BlackRock | 4,662,900 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,136,333 | 0 | 0 | 313,904 | Mixed |
| Capital Group | 3,309,597 | 0 | 0 | 0 | For |
| Invesco | 3,074,252 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 2,341,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,809,744 | 0 | 0 | 0 | For |
| Federated Hermes | 1,770,539 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 1,750,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 0 | 0 | 0 | 1,651,800 | Withhold |
| Lord Abbett | 1,552,726 | 0 | 0 | 0 | For |
| Charles Schwab | 1,469,568 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 743,506 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 325,635 | 0 | 0 | 325,398 | Mixed |
| Victory Capital | 0 | 0 | 0 | 564,540 | Withhold |
| Goldman Sachs | 7,195 | 0 | 0 | 551,541 | Withhold |
| FRANKLIN STRATEGIC SERIES | 553,257 | 0 | 0 | 0 | For |
| American Century | 0 | 0 | 0 | 548,018 | Withhold |
| AllianceBernstein | 0 | 0 | 0 | 517,922 | Withhold |
| ALGER FUNDS | 0 | 0 | 0 | 480,988 | Withhold |
| Jackson National | 293,554 | 0 | 0 | 172,282 | Mixed |
| ARK ETF Trust | 446,882 | 0 | 0 | 0 | For |
| Equitable | 192,309 | 0 | 0 | 246,059 | Mixed |
| Principal | 0 | 0 | 0 | 392,815 | Withhold |
Fund voting reports, all 127 managers: 52,298,401 for, 10,339,691 withheld, 80 abstained, 152 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 0 | 0 | 0 | 815,917 | Withhold |
| Keel Point, LLC | 0 | 0 | 0 | 2,167 | Withhold |
| Berkeley Capital Partners, LLC | 110 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 25 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 135 for, 818,084 withheld.
Combines 11 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer compensation.
Guardant Health, Inc.’s own tally for this item (“3. A proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers”): 98,236,639 for, 9,905,190 against, per its Form 8-K filed June 18, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Not approved, in the filing’s own words: “Proposal 3 in the Proxy Statement, a proposal to approve, on an advisory (non-binding) basis, the compensation of the Company's named executive officers, was not approved by the following vote:”
Filing and tally disagree. The company's filing says not approved; its own tally shows 91% FOR. Both are shown; read the filing.
Support: 91% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,138,116 | 6 | 1 | 0 | For |
| Fidelity | 7,516,018 | 0 | 0 | 0 | For |
| BlackRock | 4,662,900 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,450,237 | 0 | 0 | 0 | For |
| Capital Group | 0 | 3,309,597 | 0 | 0 | Against |
| Invesco | 11,499 | 3,062,753 | 0 | 0 | Against |
| MUTUAL FUND SERIES TRUST | 2,341,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,809,744 | 0 | 0 | 0 | For |
| Federated Hermes | 1,770,539 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 1,750,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,651,800 | 0 | 0 | 0 | For |
| Lord Abbett | 1,552,726 | 0 | 0 | 0 | For |
| Charles Schwab | 1,469,568 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 743,506 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 651,033 | 0 | 0 | 0 | For |
| Victory Capital | 564,540 | 0 | 0 | 0 | For |
| Goldman Sachs | 558,736 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 553,257 | 0 | 0 | 0 | For |
| American Century | 0 | 548,018 | 0 | 0 | Against |
| AllianceBernstein | 517,922 | 0 | 0 | 0 | For |
| ALGER FUNDS | 480,988 | 0 | 0 | 0 | For |
| Jackson National | 197,144 | 268,692 | 0 | 0 | Mixed |
| ARK ETF Trust | 446,882 | 0 | 0 | 0 | For |
| Equitable | 438,368 | 0 | 0 | 0 | For |
| Principal | 392,815 | 0 | 0 | 0 | For |
Fund voting reports, all 128 managers: 54,772,263 for, 7,825,174 against, 41,735 abstained, 152 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 7,570,699 | 0 | 0 | 0 | For |
| BlackRock | 4,446,675 | 0 | 0 | 0 | For |
| Fidelity | 4,426,560 | 0 | 0 | 0 | For |
| Invesco | 11,499 | 3,948,607 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 3,528,924 | 0 | 0 | 0 | For |
| Capital Group | 0 | 3,346,599 | 0 | 0 | Against |
| Deep Track Capital, LP | 2,958,122 | 0 | 0 | 0 | For |
| FRANKLIN ADVISERS INC | 2,924,278 | 0 | 0 | 0 | For |
| State Street | 2,449,771 | 4,215 | 0 | 0 | For |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,419,378 | 0 | 0 | 0 | For |
| Federated Hermes | 1,861,891 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD OVERSEAS LTD | 1,770,782 | 0 | 0 | 0 | For |
| LORD, ABBETT & CO. LLC | 1,746,891 | 0 | 0 | 0 | For |
| AllianceBernstein | 1,688,929 | 0 | 0 | 0 | For |
| BAILLIE GIFFORD & CO LTD | 1,593,125 | 0 | 0 | 0 | For |
| Charles Schwab | 1,481,276 | 0 | 0 | 0 | For |
| Goldman Sachs | 1,331,092 | 0 | 0 | 0 | For |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 1,325,874 | 0 | 0 | 0 | For |
| John Hancock | 1,315,611 | 0 | 0 | 0 | For |
| Hood River Capital Management LLC | 1,225,872 | 0 | 0 | 0 | For |
| UBS | 1,134,882 | 0 | 0 | 0 | For |
| Vanguard | 1,089,158 | 0 | 0 | 0 | For |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,014,062 | 0 | 0 | 0 | For |
| Northern Trust | 990,463 | 0 | 0 | 0 | For |
| CADIAN CAPITAL MANAGEMENT, LP | 903,648 | 0 | 0 | 0 | For |
Institutional-manager reports, all 393 managers: 70,849,781 for, 9,579,061 against, 89,348 abstained, 5,562 not voted, 27,274 1 year. Showing the 25 largest; see all in the interactive database.
Combines 6 wordings of this item as funds reported it.
100% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: Non-binding advisory vote on the frequency of stockholder advisory votes regarding compensation of our named executive officers.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| MUTUAL FUND SERIES TRUST | 0 | 0 | 0 | 0 | -- |
| Columbia Threadneedle | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| Franklin Custodian Funds | 0 | 0 | 0 | 0 | -- |
| Capitol Series Trust | 0 | 0 | 0 | 0 | -- |
| Lord Abbett | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Manager Directed Portfolios | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Victory Capital | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| FRANKLIN STRATEGIC SERIES | 0 | 0 | 0 | 0 | -- |
| American Century | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| ALGER FUNDS | 0 | 0 | 0 | 0 | -- |
| Jackson National | 0 | 0 | 0 | 0 | -- |
| ARK ETF Trust | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Principal | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 127 managers: 182,741 for, 41,734 abstained, 152 not voted, 62,245,853 1 year, 105,889 3 year, 295 unknown. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| T. Rowe Price | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| Capital Group | 0 | 0 | 0 | 0 | -- |
| Deep Track Capital, LP | 0 | 0 | 0 | 0 | -- |
| FRANKLIN ADVISERS INC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| FULLER & THALER ASSET MANAGEMENT, INC. | 0 | 0 | 0 | 0 | -- |
| Federated Hermes | 0 | 0 | 0 | 0 | -- |
| BAILLIE GIFFORD OVERSEAS LTD | 0 | 0 | 0 | 0 | -- |
| LORD, ABBETT & CO. LLC | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| BAILLIE GIFFORD & CO LTD | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| Hood River Capital Management LLC | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| CADIAN CAPITAL MANAGEMENT, LP | 0 | 0 | 0 | 0 | -- |
Institutional-manager reports, all 378 managers: 620,674 for, 1 abstained, 5,562 not voted, 78,723,154 1 year, 141,786 3 year, 1,116 unknown, 50 2 year. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
99.9% Approved · of votes cast
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as Guardant Health, Inc.'s independent registered public accounting firm for the year ending December 31, 2026.
Guardant Health, Inc.’s own tally for this item (“2. A proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026”): 115,899,030 for, 15,250 against — passed, per its Form 8-K filed June 18, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Proposal 2 in the Proxy Statement, a proposal to ratify the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the year ending December 31, 2026, was approved by the following vote:”
Support: 99.9% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 13,138,122 | 0 | 0 | 0 | For |
| Fidelity | 7,516,018 | 0 | 0 | 0 | For |
| BlackRock | 4,662,900 | 0 | 0 | 0 | For |
| T. Rowe Price | 4,450,237 | 0 | 0 | 0 | For |
| Capital Group | 3,309,597 | 0 | 0 | 0 | For |
| Invesco | 3,074,252 | 0 | 0 | 0 | For |
| MUTUAL FUND SERIES TRUST | 2,341,650 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 1,809,744 | 0 | 0 | 0 | For |
| Federated Hermes | 1,770,539 | 0 | 0 | 0 | For |
| Franklin Custodian Funds | 1,750,000 | 0 | 0 | 0 | For |
| Capitol Series Trust | 1,651,800 | 0 | 0 | 0 | For |
| Lord Abbett | 1,552,726 | 0 | 0 | 0 | For |
| Charles Schwab | 1,469,568 | 0 | 0 | 0 | For |
| Manager Directed Portfolios | 743,506 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 651,033 | 0 | 0 | 0 | For |
| Victory Capital | 564,540 | 0 | 0 | 0 | For |
| Goldman Sachs | 558,736 | 0 | 0 | 0 | For |
| FRANKLIN STRATEGIC SERIES | 553,257 | 0 | 0 | 0 | For |
| American Century | 548,018 | 0 | 0 | 0 | For |
| AllianceBernstein | 517,922 | 0 | 0 | 0 | For |
| ALGER FUNDS | 480,988 | 0 | 0 | 0 | For |
| Jackson National | 465,836 | 0 | 0 | 0 | For |
| ARK ETF Trust | 446,882 | 0 | 0 | 0 | For |
| Equitable | 438,368 | 0 | 0 | 0 | For |
| Principal | 392,815 | 0 | 0 | 0 | For |
Fund voting reports, all 127 managers: 62,596,437 for, 41,734 abstained, 152 not voted. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Erste Asset Management GmbH | 815,917 | 0 | 0 | 0 | For |
| Keel Point, LLC | 2,167 | 0 | 0 | 0 | For |
| Berkeley Capital Partners, LLC | 110 | 0 | 0 | 0 | For |
| Legacy Capital Wealth Partners, LLC | 25 | 0 | 0 | 0 | For |
Institutional-manager reports, all 4 managers: 818,219 for.
Not shown here: this season’s fund filings also report 1 item from the meeting of June 18, 2025, which belongs to the 2024-2025 season. A meeting outside this season’s July 1 to June 30 window is not counted in this page’s items or in its totals of asset managers and fund votes.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 132,599,929 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 9.91% |
| 2 | Fidelity | 5.67% |
| 3 | BlackRock | 3.52% |
| 4 | T. Rowe Price | 3.36% |
| 5 | Capital Group | 2.50% |
| 6 | Invesco | 2.32% |
| 7 | MUTUAL FUND SERIES TRUST | 1.77% |
| 8 | Columbia Threadneedle | 1.36% |
| 9 | Federated Hermes | 1.34% |
| 10 | Franklin Custodian Funds | 1.32% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | T. Rowe Price | 5.71% |
| 2 | BlackRock | 3.35% |
| 3 | Fidelity | 3.34% |
| 4 | Invesco | 2.99% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 2.66% |
| 6 | Capital Group | 2.52% |
| 7 | Deep Track Capital, LP | 2.23% |
| 8 | FRANKLIN ADVISERS INC | 2.21% |
| 9 | State Street | 1.85% |
| 10 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.82% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Vanguard Group | 9.17% | 13F |
| BlackRock | 8.71% | 13F |
| T. Rowe Price | 5.30% | 13F |
| Invesco | 3.73% | 13F |
| Goldman Sachs | 3.35% | 13F |
| Two Sigma | 3.19% | 13F |
| FMR (Fidelity) | 3.10% | 13F |
| Franklin Templeton | 2.60% | 13F |
Percentages above are of 132,599,929 shares outstanding, as reported by Guardant Health, Inc. on its Form 10-Q dated May 1, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Guardant Health, Inc.’s 10-Q dated May 1, 2026. This page is a static snapshot rebuilt weekly on October 25, 2026; a live search always shows the current data.
At Guardant Health, Inc.'s shareholder meeting held June 17, 2026, in the 2025-2026 proxy season, 491 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 3,826 separate fund positions. On the most widely held item on that ballot — Non-binding advisory vote to approve Guardant Health, Inc.'s named executive officer… — Guardant Health, Inc.'s filing reports the proposal as not approved, with 91% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). The company's filing says not approved; its own tally shows 91% FOR. Both are shown; read the filing. Source: Guardant Health, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 18, 2026.
Guardant Health, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Download data (CSV): ballot items · votes by manager · column guide.